(3R)-Quinuclidin-3-amine dihydrochloride, 97.0%, 100g

4-Amino-2-methylpyrimidine-5-carbonitrile, 97.0%, 25g

4-Aminobutyraldehyde Dimethyl Acetal>98.0%(GC)(T)25mL

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 0.10 µm, 1 Piece(s)

4-(3-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)propoxy)benzamide, 98%, 1mg

(S)-tert-Butyl 3-[(propan-2-yl)carbamoyl]aminolpiperidine-1-carboxylate, 1g

6-Bromo-2-methylbenzo[d]oxazole, 95.0%, 5g

N,O-Bis(trimethylsilyl)acetamide [Trimethylsilylating Agent]>80.0%(GC)10mL

TERT-BUTYL 4-[4-(3,3-DIMETHYLBUTYL)ANILINO]-1-PIPERIDINECARBOXYLATE, 95.0%, 100mg

Brinzolamide>98.0%(HPLC)25mg

(2e)-3-(1h-Pyrrol-2-yl)prop-2-enoic acid, 98%, 500mg

2-Bromo-1-naphthaldehyde, 95.0%, 10g

3-PROPOXY-AZETIDINE HCL, 97.0%, 1g